HIPAA Alert: Potential Data Breach Learn More

Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic

844-346-7222
Search
Close this search box.
844-346-7222
REQUEST AN APPOINTMENT

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.

298 Clinical Trials
Breast Cancer Clinical Trials Pilot Accepting Patients
nct/study# NA / IOTA-STUDY

Investigating Obstacles To Treatment Adherence For Metastatic Breast Cancer

Learn More
Breast Cancer Clinical Trials NA Accepting Patients
nct/study# NA / U01-COTA-DATABASE

Optimizing Personalized Care Using Economic Studies Of Genomic Testing

Learn More
Breast Cancer Clinical Trials Phase II Accepting Patients
nct/study# NCT03487666 / 2017-1535-CA209-8CL

OXEL: A Pilot Study Of Immune Checkpoint Or Capecitabine Or Combination Therapy As Adjuvant Therapy For Triple Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy

Learn More
Breast Cancer Clinical Trials Phase II Accepting Patients
nct/study# NCT02400658 / BREAST-IORT

A Prospective Multi-Site Single- Arm Phase II Study To Investigate Breast IORT – The Efficacy Of Single-Fraction Intraoperative Radiation Treatment Using A Multi-Lumen Balloon Applicator And In-Room CT Imaging For The Treatment Of Early-Stage Breast Cancer.

Learn More
Breast Cancer Clinical Trials Ib/II Active
nct/study#  NCT04802759 / CO42867 - Morpheus BC

A Phase Ib/Ii, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Treatment Combinations In Patients With Breast Cancer (Morpheus-Breast Cancer)

Learn More
Breast Cancer Clinical Trials Ib/II Accepting Patients
nct/study# NCT03424005 / CO40115 - Morpheus TNBC

A Phase Ib/Ii,Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Triple-Negative Breast Cancer (Morpheus-Tnbc)

Learn More

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

request an appointment
Community Oncology Alliance Logo
COA Patient Advocacy Network Logo
OncLive® Strategic Alliance Partner Badge
Pharmacy Times® Strategic Alliance Partner Badge
Targeted Oncology Strategic Alliance Partner Badge

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.